{"id":"NCT01287364","sponsor":"Sumitomo Pharma America, Inc.","briefTitle":"Evaluation of a Novel Questionnaire to Assess Patient Satisfaction With and Preference of Intranasal Corticosteroids for the Treatment of Allergic Rhinitis","officialTitle":"Psychometric Evaluation of a Novel Questionnaire Designed to Assess Patient Satisfaction With and Preference of Intranasal Corticosteroids Administered Via HFA Aerosol or Aqueous Suspension Used for the Treatment of Allergic Rhinitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-02","primaryCompletion":"2011-04","completion":"2011-04","firstPosted":"2011-02-01","resultsPosted":"2012-10-31","lastUpdate":"2012-11-02"},"enrollment":185,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"NONE","primaryPurpose":null},"conditions":["Perennial Allergic Rhinitis"],"interventions":[{"type":"DRUG","name":"ciclesonide hydrofluoroalkane (HFA) nasal aerosol","otherNames":[]},{"type":"DRUG","name":"mometasone nasal inhalation","otherNames":["NasonexÂ®"]}],"arms":[{"label":"ciclesonide HFA followed by mometasone","type":"EXPERIMENTAL"},{"label":"mometasone followed by ciclesonide HFA","type":"ACTIVE_COMPARATOR"}],"summary":"This is an open-label, randomized, multicenter, 2-way crossover study in subjects 12 years or older with perennial allergic rhinitis (PAR) to evaluate the psychometric properties of a novel-patient administered assessment of treatment satisfaction with and preference of an Internasal Corticosteroid (INCS)","primaryOutcome":{"measure":"Treatment Satisfaction Subscales (Interference, Regimen Adaptation, Role Limitations, Sensory Impact, Regimen Difficulties, Burden, Hassle, Regimen Management, and Perceived Relief)Reliability Statistics","timeFrame":"Day 1 (Pre-treatment) through Day 7 Treatment Period 2","effectByArm":[{"arm":"Average Cronbach's Alpha (Raw) Coefficients","deltaMin":0.971,"sd":null},{"arm":"Average Cronbach's Alpha (Standardized) Coefficients","deltaMin":0.972,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":18},"locations":{"siteCount":6,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":175},"commonTop":["Epistaxis","Instillation Site Discomfort","Upper Respiratory Tract Infection"]}}